JP6351639B2 - リンパ節検出のための低浸透圧溶液 - Google Patents

リンパ節検出のための低浸透圧溶液 Download PDF

Info

Publication number
JP6351639B2
JP6351639B2 JP2015562299A JP2015562299A JP6351639B2 JP 6351639 B2 JP6351639 B2 JP 6351639B2 JP 2015562299 A JP2015562299 A JP 2015562299A JP 2015562299 A JP2015562299 A JP 2015562299A JP 6351639 B2 JP6351639 B2 JP 6351639B2
Authority
JP
Japan
Prior art keywords
suspension
hypotonic
patient
lymph node
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015562299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512221A5 (enExample
JP2016512221A (ja
Inventor
アンドリュー ピー． ショークロス，
アンドリュー ピー． ショークロス，
ジョン ゴンザレス−カバヤル，
ジョン ゴンザレス−カバヤル，
マーク ブラウン，
マーク ブラウン，
ロブ ターナー，
ロブ ターナー，
Original Assignee
エンドマグネティクス リミテッド
エンドマグネティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エンドマグネティクス リミテッド, エンドマグネティクス リミテッド filed Critical エンドマグネティクス リミテッド
Publication of JP2016512221A publication Critical patent/JP2016512221A/ja
Publication of JP2016512221A5 publication Critical patent/JP2016512221A5/ja
Application granted granted Critical
Publication of JP6351639B2 publication Critical patent/JP6351639B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Treatment Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2015562299A 2013-03-11 2014-03-10 リンパ節検出のための低浸透圧溶液 Active JP6351639B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361775780P 2013-03-11 2013-03-11
US61/775,780 2013-03-11
PCT/GB2014/050698 WO2014140543A1 (en) 2013-03-11 2014-03-10 Hypoosmotic solutions for lymph node detection

Publications (3)

Publication Number Publication Date
JP2016512221A JP2016512221A (ja) 2016-04-25
JP2016512221A5 JP2016512221A5 (enExample) 2017-03-09
JP6351639B2 true JP6351639B2 (ja) 2018-07-04

Family

ID=50342341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015562299A Active JP6351639B2 (ja) 2013-03-11 2014-03-10 リンパ節検出のための低浸透圧溶液

Country Status (10)

Country Link
US (2) US9808539B2 (enExample)
EP (1) EP2968560B1 (enExample)
JP (1) JP6351639B2 (enExample)
CN (1) CN105283202B (enExample)
AU (1) AU2014229811B2 (enExample)
BR (1) BR112015022129B1 (enExample)
CA (1) CA2904779C (enExample)
ES (1) ES2803506T3 (enExample)
MX (1) MX378185B (enExample)
WO (1) WO2014140543A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016154552A1 (en) * 2015-03-25 2016-09-29 Lodespin Labs, Llc The use of iron oxide nanoparticles in magnetically guided sentinel lymph node biopsy
ES2833377T3 (es) 2015-06-04 2021-06-15 Endomagnetics Ltd Materiales marcadores y formas de localizar un marcador magnético

Family Cites Families (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2614164A (en) 1947-11-12 1952-10-14 Schlumberger Well Surv Corp Mutual inductance system
US3449662A (en) 1963-10-16 1969-06-10 American Mach & Foundry Magnetic inspection method and apparatus using resilient magnetizing means and resilient sensors
US3445928A (en) 1966-03-25 1969-05-27 Bunker Ramo Magnetometer method of manufacture
US4324255A (en) 1980-03-07 1982-04-13 Barach John P Method and apparatus for measuring magnetic fields and electrical currents in biological and other systems
GB2109112A (en) 1981-10-06 1983-05-25 Pantatron Systems Limited Eddy current test probe
JPH0768117B2 (ja) 1983-05-06 1995-07-26 ベスター・インコーポレイテツド 薬剤放出調整用小胞製剤
US5261403A (en) 1987-03-30 1993-11-16 Hitachi, Ltd. Magnetic resonance imaging apparatus
US5414356A (en) 1987-09-21 1995-05-09 Hitachi, Ltd. Fluxmeter including squid and pickup coil with flux guiding core and method for sensing degree of deterioration of an object
US4825162A (en) 1987-12-07 1989-04-25 General Electric Company Nuclear magnetic resonance (NMR) imaging with multiple surface coils
JP2613275B2 (ja) 1988-09-16 1997-05-21 株式会社日立製作所 超電導量子干渉素子を用いた磁束計
EP0390935A1 (de) 1989-03-29 1990-10-10 Siemens Aktiengesellschaft Verfahren zum Kalibrieren von Mehrkanal-Squid-Systemen mit Gradiometern beliebiger Ordnung
US5442289A (en) 1989-07-31 1995-08-15 Biomagnetic Technologies, Inc. Biomagnetometer having flexible sensor
DE4003330A1 (de) 1990-02-05 1991-08-08 Foerster Inst Dr Friedrich Wirbelstrompruefgeraet
US5005001A (en) 1990-04-05 1991-04-02 Pitney Bowes Inc. Field generation and reception system for electronic article surveillance
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
IL98744A0 (en) * 1990-07-06 1992-07-15 Gen Hospital Corp Method of studying biological tissue using monocrystalline particles
CA2088918C (en) 1991-06-04 1996-07-02 Seigo Ando Magnetic detecting method and apparatus therefor
US5293119A (en) 1992-02-20 1994-03-08 Sqm Technology, Inc. Electromagnetic microscope for evaluation of electrically conductive and magnetic materials
JP2882167B2 (ja) 1992-03-06 1999-04-12 ダイキン工業株式会社 Ｓｑｕｉｄ磁束計
FR2689638B1 (fr) 1992-04-06 1996-08-09 Aerospatiale Capteur a courants de foucault.
DE4226814A1 (de) 1992-08-13 1994-02-17 Philips Patentverwaltung Spulenanordnung für MR-Untersuchungen der Mamma
US6023165A (en) 1992-09-28 2000-02-08 Fonar Corporation Nuclear magnetic resonance apparatus and methods of use and facilities for incorporating the same
US5575794A (en) 1993-02-12 1996-11-19 Walus; Richard L. Tool for implanting a fiducial marker
JPH06324021A (ja) 1993-03-16 1994-11-25 Hitachi Ltd 非破壊検査装置
US5537037A (en) 1993-03-16 1996-07-16 Hitachi, Ltd. Apparatus with cancel coil assembly for cancelling a field parallel to an axial direction to the plural coils and to a squid pick up coil
DE69432834T2 (de) 1993-04-26 2004-05-13 St. Louis University Anzeige der Lage einer chirurgischen Sonde
US5590654A (en) 1993-06-07 1997-01-07 Prince; Martin R. Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5363845A (en) 1993-08-13 1994-11-15 Medical Advances, Inc. Breast coil for magnetic resonance imaging
BE1007459A3 (nl) 1993-08-24 1995-07-04 Philips Electronics Nv Magnetisch resonantie apparaat.
US5437280A (en) 1993-09-20 1995-08-01 Hussman; Karl L. Magnetic resonance breast localizer
JPH0815229A (ja) 1994-06-27 1996-01-19 Mitsubishi Heavy Ind Ltd 高分解能渦電流探傷装置
US5402094A (en) 1994-08-15 1995-03-28 Enge; Harald A. MRI mammography magnet
EP0781114B1 (en) 1994-09-16 2005-05-25 Ethicon Endo-Surgery, Inc. Devices for defining and marking tissue
JP3910222B2 (ja) 1995-03-10 2007-04-25 株式会社豊田中央研究所 疲労度測定装置
US5657756A (en) 1995-06-07 1997-08-19 Ctf Systems Inc. Method and systems for obtaining higher order gradiometer measurements with lower order gradiometers
JP3580905B2 (ja) 1995-06-13 2004-10-27 大日本印刷株式会社 磁気センサ
JP3499054B2 (ja) 1995-07-11 2004-02-23 独立行政法人 国立印刷局 安全保護紙の真偽判定装置
US5842986A (en) 1995-08-16 1998-12-01 Proton Sciences Corp. Ferromagnetic foreign body screening method and apparatus
DE19532676C1 (de) 1995-09-05 1997-05-07 Inst Physikalische Hochtech Ev Anordnung zur Bestimmung der Position eines Markers in einem Hohlraum innerhalb des Organismus eines Lebewesens
GB9600427D0 (en) * 1996-01-10 1996-03-13 Nycomed Imaging As Contrast media
PL328199A1 (en) 1996-01-25 1999-01-18 Schering Ag Improved concentrated intravascular injection and infusion solutions
EP0902687A1 (en) 1996-03-11 1999-03-24 Focal, Inc. Polymeric delivery of radionuclides and radiopharmaceuticals
US6549800B1 (en) 1996-04-25 2003-04-15 Johns Hopkins Unversity School Of Medicine Methods for in vivo magnetic resonance imaging
JPH1038854A (ja) 1996-07-17 1998-02-13 Agency Of Ind Science & Technol 導電性材料の非破壊検査方法および装置
EP1284123B1 (en) 1996-08-12 2005-07-20 Ethicon Endo-Surgery, Inc. Apparatus for marking tissue
WO1998007052A1 (en) 1996-08-16 1998-02-19 Jon Neal Weaver Anti-shoplifting security system
US5844140A (en) 1996-08-27 1998-12-01 Seale; Joseph B. Ultrasound beam alignment servo
US5997473A (en) 1996-09-06 1999-12-07 Olympus Optical Co., Ltd. Method of locating a coil which consists of determining the space occupied by a source coil generating a magnetic field
DE29724862U1 (de) 1996-09-18 2004-12-30 Ifm Electronic Gmbh Induktiver Näherungsschalter
EP1007909A1 (de) 1996-12-27 2000-06-14 Bic-Neisse GmbH Magnetischer resonanzsensor
US6406420B1 (en) 1997-01-02 2002-06-18 Myocor, Inc. Methods and devices for improving cardiac function in hearts
AU2869900A (en) 1997-02-27 2000-08-25 Uri Rapoport Method and apparatus for detecting a magnetically responsive substance
GB9712524D0 (en) 1997-06-16 1997-08-20 Nycomed Imaging As Method
FR2770779B1 (fr) 1997-11-10 2000-07-21 Bernstein Veronique Solute hypotonique ou hypoosmolaire au plasma utilise dans le traitement de la cellulite, les fibroses, et de l'hirsutisme
US6270464B1 (en) 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6205352B1 (en) 1997-11-19 2001-03-20 Oncology Innovations, Inc. Sentinel node identification using non-isotope means
US6161034A (en) 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6347241B2 (en) 1999-02-02 2002-02-12 Senorx, Inc. Ultrasonic and x-ray detectable biopsy site marker and apparatus for applying it
CA2327816A1 (en) * 1998-04-09 1999-10-21 Nycomed Imaging As Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
WO2002039917A1 (en) 1998-05-14 2002-05-23 Calypso Medical, Inc. Systems and methods for locating and defining a target location within a human body
US5941890A (en) 1998-06-26 1999-08-24 Ethicon Endo-Surgery, Inc. Implantable surgical marker
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6230038B1 (en) 1999-02-01 2001-05-08 International Business Machines Corporation Imaging of internal structures of living bodies by sensing implanted magnetic devices
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US6173715B1 (en) 1999-03-01 2001-01-16 Lucent Medical Systems, Inc. Magnetic anatomical marker and method of use
AU4656400A (en) 1999-04-21 2000-11-17 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Method for enhancing contrast produced by mri
US6766186B1 (en) 1999-06-16 2004-07-20 C. R. Bard, Inc. Post biospy tissue marker and method of use
JP2001000430A (ja) 1999-06-24 2001-01-09 Alcare Co Ltd 画像撮影用のマ−カ−
US6835572B1 (en) 1999-10-18 2004-12-28 Institute For Magnetic Resonance Research Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement
JP2001255358A (ja) 2000-03-10 2001-09-21 Sumitomo Electric Ind Ltd 磁気センサ
WO2001076475A2 (en) 2000-04-07 2001-10-18 The Johns Hopkins University Apparatus for sensing human prostate tumor
US6889073B2 (en) 2000-05-08 2005-05-03 David A. Lampman Breast biopsy and therapy system for magnetic resonance imagers
AU2001273133A1 (en) 2000-08-10 2002-02-25 Cook Incorporated Localizer needle
US6394965B1 (en) 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc FLEXIBLE AND / OR ELASTIC BRACHYTHERAPY SEED OR STRAND
FR2823092B1 (fr) 2001-04-10 2004-03-05 Eurorad 2 6 Dispositif per-operatoire pour la localisation de tissus marques et procede utilisant un tel dispositif
JP4193382B2 (ja) 2001-07-19 2008-12-10 株式会社日立製作所 磁場計測装置
US6850065B1 (en) 2001-07-27 2005-02-01 General Electric Company MRI coil system for breast imaging
US6592608B2 (en) 2001-12-07 2003-07-15 Biopsy Sciences, Llc Bioabsorbable sealant
ITSV20010029A1 (it) 2001-08-14 2003-02-14 Esaote Spa Macchina per il rilevamento di immagini in risonanza magnetica nucleare (mri)
US20030141868A1 (en) 2001-08-23 2003-07-31 Bakharev Alexander A. High balance gradiometer
US7135978B2 (en) 2001-09-14 2006-11-14 Calypso Medical Technologies, Inc. Miniature resonating marker assembly
US7701209B1 (en) 2001-10-05 2010-04-20 Fonar Corporation Coils for horizontal field magnetic resonance imaging
JP4090722B2 (ja) 2001-10-23 2008-05-28 純一 小川 磁性流体検出装置
US20030216632A1 (en) 2001-10-29 2003-11-20 Mednovus, Inc. Ferromagnetic sensing method and apparatus
JP2003149212A (ja) 2001-11-09 2003-05-21 Japan Science & Technology Corp 非破壊検査装置
AU2002350313B2 (en) 2001-12-14 2005-12-01 Monteris Medical Inc. Hyperthermia treatment and probe therefor
JP2003315373A (ja) 2002-04-18 2003-11-06 Toshiba Corp 電流検出装置及び半導体装置
US7329414B2 (en) 2002-05-03 2008-02-12 Biopsy Sciences, Llc Biodegradable polymer for marking tissue and sealing tracts
JP4221192B2 (ja) 2002-06-14 2009-02-12 株式会社日立ハイテクノロジーズ 生体磁気計測装置
US20040162477A1 (en) 2002-10-04 2004-08-19 Olympus Corporation Apparatus for detecting magnetic fluid identifying sentinel-lymph node
US20060173283A1 (en) 2002-11-27 2006-08-03 Oskar Axelsson Method of magnetic resonance imaging
ATE428112T1 (de) 2002-12-13 2009-04-15 Mauro Marinelli Suszeptibilitatmessgerat zur nichtinvasiven messung des eisengehalts in einem kírper
US7009398B2 (en) 2003-03-20 2006-03-07 Siemens Aktiengesellschaft Portable magnetic resonance surface coil unit with an access opening for manual gripping
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US7783336B2 (en) 2003-06-06 2010-08-24 Ethicon Endo-Surgery, Inc. Subcutaneous biopsy cavity marker device
US20050033157A1 (en) 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US7744852B2 (en) 2003-07-25 2010-06-29 Rubicor Medical, Llc Methods and systems for marking post biopsy cavity sites
US7001341B2 (en) 2003-08-13 2006-02-21 Scimed Life Systems, Inc. Marking biopsy sites
US7084631B2 (en) 2003-11-19 2006-08-01 General Electric Company Magnetic resonance imaging array coil system and method for breast imaging
JP4217599B2 (ja) 2003-12-09 2009-02-04 オリンパス株式会社 磁性流体検出装置
EP1541083A3 (en) 2003-12-09 2006-03-01 Olympus Corporation Magnetic fluid detection device
US8118754B1 (en) 2007-11-15 2012-02-21 Flynn Edward R Magnetic needle biopsy
US7386338B2 (en) 2004-04-30 2008-06-10 General Electric Company Bilateral imaging apparatus
US7708751B2 (en) 2004-05-21 2010-05-04 Ethicon Endo-Surgery, Inc. MRI biopsy device
JP3896489B2 (ja) 2004-07-16 2007-03-22 国立大学法人 岡山大学 磁気検知装置及び物質判定装置
US7116094B2 (en) 2004-07-28 2006-10-03 International Business Machines Corporation Apparatus and method for transmission and remote sensing of signals from integrated circuit devices
US20080097199A1 (en) 2004-08-20 2008-04-24 David Mullen Tissue Marking Devices and Systems
US20060074295A1 (en) 2004-10-01 2006-04-06 Nexgen Combined MR coil technology in medical devices
US8280486B2 (en) 2004-10-13 2012-10-02 Suros Surgical Systems, Inc. Site marker visable under multiple modalities
US8060183B2 (en) 2004-10-13 2011-11-15 Suros Surgical Systems, Inc. Site marker visible under multiple modalities
US20100125191A1 (en) 2004-11-18 2010-05-20 Nedim Turan Sahin Mri as a therapeutic device
WO2006056739A2 (en) 2004-11-23 2006-06-01 Quantum Medical Technology Limited Surgical tag, magnetometer, and associated system
US8467849B2 (en) 2005-02-03 2013-06-18 ORGAMEND Inc. Magnetic resonance imaging device
GB2425610A (en) 2005-04-29 2006-11-01 Univ London Magnetic properties sensing system
US7831293B2 (en) 2005-05-10 2010-11-09 Advanced Clinical Solutions, Inc. Method of defining a biological target for treatment
US20060293581A1 (en) 2005-05-12 2006-12-28 Sunnybrook And Women's College Health Sciences Centre Marker device for X-ray, ultrasound and MR imaging
US7570056B2 (en) 2005-08-10 2009-08-04 Kabushiki Kaisha Toshiba Magnetic resonance imaging apparatus
GB0519391D0 (en) 2005-09-22 2005-11-02 Aion Diagnostics Ltd Imaging agents
US7479784B2 (en) 2005-10-12 2009-01-20 New York University Arrangements, systems and methods for facilitating and collecting information associated with fluxes of magnetic fields provided at various angles from one another
US20070135343A1 (en) 2005-11-01 2007-06-14 Wyeth Sodium chloride solution for drug reconstitution or dilution
US8193804B2 (en) 2005-11-16 2012-06-05 Rex Chin-Yih Hong Device for measuring AC magnetization of materials
US7702378B2 (en) 2005-11-17 2010-04-20 Breast-Med, Inc. Tissue marker for multimodality radiographic imaging
US8078260B2 (en) 2006-05-02 2011-12-13 ORGAMEND Inc. Method for improving magnetic resonance imaging of the breast
GB2439747A (en) * 2006-07-03 2008-01-09 Uni Degli Studi Di Urbino Carl Delivery of contrasting agents for magnetic resonance imaging
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
US20090024022A1 (en) 2006-10-25 2009-01-22 Siemens Corporate Research, Inc. System and method for lymph node imaging using co-registration of ct and mr imagery
US20080146914A1 (en) 2006-12-19 2008-06-19 General Electric Company System, method and apparatus for cancer imaging
DE102007009016A1 (de) 2007-02-23 2008-08-28 Siemens Ag Markierung und Verfahren zur Positionsbestimmung eines Zielgewebes
US20080228164A1 (en) 2007-03-14 2008-09-18 Nicoson Zachary R Implant delivery system
US8239008B2 (en) 2007-04-13 2012-08-07 Ethicon Endo-Surgery, Inc. Sentinel node identification using fluorescent nanoparticles
WO2008131391A1 (en) 2007-04-23 2008-10-30 Device Evolutions, Llc Surgical metal detection apparatus and methods
US8137320B2 (en) 2007-05-01 2012-03-20 Suros Surgical Systems, Inc. Securement for a surgical site marker and deployment device for same
US9763597B2 (en) 2007-05-03 2017-09-19 Wisconsin Alumni Research Foundation Local MRI breast coil and method of use
US20090082662A1 (en) 2007-09-24 2009-03-26 Israel Henry M Mri breast image magnet structure
DE102007046186A1 (de) 2007-09-26 2009-04-02 Amedo Smart Tracking Solutions Gmbh Gewebemarkierung
US8731635B2 (en) 2007-11-07 2014-05-20 University of Pittsburgh—of the Commonwealth System of Higher Education Coils for magnetic resonance spectroscopy and imaging of human breast
US8050742B2 (en) 2008-07-30 2011-11-01 Devicor Medical Products, Inc. Biopsy device
DE102008048291B4 (de) 2008-09-22 2012-02-16 Siemens Aktiengesellschaft Brustspulenanordnung für Magnetresonanzanwendungen
EP3847959B1 (en) 2009-06-26 2024-09-11 Cianna Medical, Inc. System for localizing markers or tissue structures within a body
GB0916334D0 (en) 2009-09-17 2009-10-28 Renovo Ltd Inhibition of tendon adhesions
JP2011079781A (ja) * 2009-10-08 2011-04-21 Keio Gijuku センチネルリンパ節の造影剤ないし同定剤、温熱療法剤
US10634741B2 (en) * 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
JP5678565B2 (ja) * 2009-12-08 2015-03-04 Jnc株式会社 磁性微粒子およびその製造方法
US20130236530A1 (en) * 2012-03-09 2013-09-12 Howard Rosen Pain reliever composition
US20140018663A1 (en) * 2012-07-16 2014-01-16 Endomagnetics Ltd. Magnetic Marker for Surgical Localization

Also Published As

Publication number Publication date
US20180028692A1 (en) 2018-02-01
MX378185B (es) 2025-03-07
BR112015022129B1 (pt) 2022-04-19
ES2803506T3 (es) 2021-01-27
AU2014229811B2 (en) 2018-02-15
EP2968560B1 (en) 2020-04-29
BR112015022129A2 (pt) 2017-07-18
MX2015012587A (es) 2016-10-13
US20140314679A1 (en) 2014-10-23
AU2014229811A1 (en) 2015-09-24
CA2904779C (en) 2019-04-09
CA2904779A1 (en) 2014-09-18
US9808539B2 (en) 2017-11-07
EP2968560A1 (en) 2016-01-20
CN105283202B (zh) 2019-04-23
JP2016512221A (ja) 2016-04-25
CN105283202A (zh) 2016-01-27
WO2014140543A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
Hu et al. Silk embolic material for catheter‐directed endovascular drug delivery
Kovacs et al. MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain
Chertok et al. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics
CN103536972B (zh) 磁共振成像可检测的液体栓塞组合物及其制备和应用
Liu et al. 131I-labeled copper sulfide-loaded microspheres to treat hepatic tumors via hepatic artery embolization
Wu et al. Magnetite nanocluster@ poly (dopamine)-PEG@ indocyanine green nanobead with magnetic field-targeting enhanced MR imaging and photothermal therapy in vivo
Lee et al. A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment
Tang et al. A neutrophil-mimetic magnetic nanoprobe for molecular magnetic resonance imaging of stroke-induced neuroinflammation
Chanda et al. Gold nanoparticle based X-ray contrast agent for tumor imaging in mice and dog: a potential nanoplatform for computer tomography theranostics
Gao et al. A smart, phase transitional and injectable DOX/PLGA-Fe implant for magnetic-hyperthermia-induced synergistic tumor eradication
Sawyer et al. Nanoparticle-based evaluation of blood–brain barrier leakage during the foreign body response
CA3063420A1 (en) Treatment of epithelial cysts by intracystic injection of antineoplastic particles
JP7481252B2 (ja) 標的放射線治療誘発性血管完全性を保護する方法
Al-Jamal et al. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes
Lee et al. Improved drug targeting to liver tumors after intra-arterial delivery using superparamagnetic iron oxide and iodized oil: preclinical study in a rabbit model
Chen et al. Magnetically targeted nanoparticles for imaging-guided photothermal therapy of cancer
EP3291818B1 (en) Compositions and methods for delivering therapeutic agents into the colon
Liang et al. Intra-arterial delivery of superparamagnetic iron-oxide nanoshell based chemoembolization system for the treatment of liver tumor
US20180028692A1 (en) Hypoosmotic Solutions for Lymph Node Detection
Kee et al. Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes
US12350341B2 (en) Methods for the treatment of cancer and benign lesions by ablation
JP2024528328A (ja) 生体適合性画像化粒子、その合成、及び画像技術におけるその使用
Nayak et al. Complex imaging features of accidental cerebral intraventricular gadolinium administration: Report of 2 cases
US20130078288A1 (en) Method of Treating Cancer
CN103251963A (zh) 一种治疗肝癌的合剂

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170201

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170201

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170804

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171102

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180205

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180523

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180605

R150 Certificate of patent or registration of utility model

Ref document number: 6351639

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250